Subscribe: Newswise Feature Channel: Respiratory Diseases and Disorders
Added By: Feedage Forager Feedage Grade A rated
Language: English
cancer  cystic fibrosis  cystic  drug  fibrosis  lung cancer  lung  new  patients  research  researchers  study  treatment  university 
Rate this Feed
Rating: 3.3 starRating: 3.3 starRating: 3.3 starRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Newswise Feature Channel: Respiratory Diseases and Disorders

Newswise Feature Channel: Respiratory Diseases and Disorders

This feature channel highlights experts, research, and feature stories related to the respiratory and pulmonary system

Copyright: Copyright 2017 Newswise

Cystic Fibrosis: Discovery of a Key Molecule for Improving Treatments

Tue, 12 Dec 2017 05:00:00 EST

Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have identified a promising solution to improving treatments offered to patients with cystic fibrosis.

10 Tips for Staying Healthy During Wildfires: ATS Recommendations

Mon, 11 Dec 2017 11:05:31 EST

(image) This past weekend brought fierce Santa Ana Winds to Southern California that are expected to last all week. As of this writing, major fires are burning in Ventura County and other areas within Los Angeles County. The South Coast Air Quality Management District lists the following areas of direct smoke impacts:

Lung Cancer Prevention: 12 Tips to Reduce Your Risk

Fri, 08 Dec 2017 08:05:34 EST

(image) Remember when your mom always told you "what you do now will catch up with you when you're older?" She wasn't lying. Lung cancer is a disease that mostly affects the elderly, with 83 percent of those living with cancer being 60-years-of-age or older, but reducing your risk of getting lung cancer starts when you're young.

Consuming Sugary Drinks During Pregnancy May Increase Asthma Risk in Mid-childhood

Fri, 08 Dec 2017 00:15:00 EST

(image) Dec. 5, 2017─Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research published online in the Annals of the American Thoracic Society.

Cystic Fibrosis Drug Shows Promise in Children as Young as 1 Year of Age

Thu, 07 Dec 2017 16:45:49 EST

(image) Ann & Robert H. Lurie Children's Hospital of Chicago is one of the study sites in the open label Phase 3 study that showed safety and effectiveness of the cystic fibrosis drug Kalydeco (ivacaftor) in children ages 1 to 2 years. Based on these results, Vertex Pharmaceuticals Inc., (Nasdaq: VRTX) plans to submit applications for the drug in this age group to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Kalydeco is currently approved by the FDA for the treatment of cystic fibrosis in patients aged 2 years and older.

Study First to Sequence DNA From a Single Mitochondria

Wed, 06 Dec 2017 13:05:51 EST

(image) DNA sequences between mitochondria within a single cell are vastly different, found researchers. This knowledge will help to better illuminate the underlying mechanisms of many disorders that start with accumulated mutations in individual mitochondria and provide clues about how patients might respond to specific therapies.

San Diego Team Wins $ 6.9 Million Grant to Establish PrecISE Network Clinical Center

Wed, 06 Dec 2017 11:05:46 EST

(image) A team of physicians, scientists and biostatisticians from La Jolla Institute for Allergy and Immunology and UC San Diego School of Medicine joined forces across institutions to successfully compete for an $6.9 million grant to establish one of only 10 PrecISE Network Clinical Centers nationwide.

Tulane Expert Available to Comment on Jerusalem

Wed, 06 Dec 2017 10:05:06 EST


Exposure to Wildfire Smoke In Utero Lowers Birthweight: @UNLV Study

Tue, 05 Dec 2017 17:05:10 EST

(image) Economics researchers capitalize on the dynamics of wildfires to prove infants' proximity to smoke pollution while in utero affects birthweight.

New TB Drugs Possible with Understanding of Old Antibiotic

Tue, 05 Dec 2017 05:00:00 EST

(image) Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.

Faith in Cancer Care Team Keeps New Mexico Woman at UAMS

Mon, 04 Dec 2017 10:05:27 EST

(image) TIna Farber arrived in Arkansas with one thing on her mind -- meeting her two new grandbabies. Her son's third child had arrived in April, and her daughter was expecting her third about one month later.

Invasive Cells in Head and Neck Tumors Predict Cancer Spread

Thu, 30 Nov 2017 12:00:00 EST

(image) Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition -- which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment -- are more likely to invade and spread to other parts of the body, according to a new study led by researchers from Mass. Eye and Ear, Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard.

2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients

Thu, 30 Nov 2017 12:00:00 EST

(image) Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together, achieved robust anti-tumor responses in human cancer cell lines and mice.

'Aggressive' Surgery Is Best Treatment Option for Early Stage Lung Cancer

Thu, 30 Nov 2017 00:00:00 EST

(image) Patients with early stage lung cancer live longer when they receive a lobectomy--the most common type of operation for the disease--rather than a less extensive operation or radiation treatment.

Synthetic Cannabis-Like Drug Reduces Sleep Apnea

Tue, 28 Nov 2017 15:40:10 EST

(image) A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health.

New Study Finds Mycobacteria Can Sense Presence of Proteins That Cause Disease

Mon, 27 Nov 2017 15:25:10 EST

(image) The study from the University of Notre Dame and Michigan State University could help researchers identify how to tone down the ability of mycobacteria to cause disease and help them in treating infection.

New Simple Test Could Help Cystic Fibrosis Patients Find Best Treatment

Tue, 21 Nov 2017 10:05:53 EST

(image) While new CF drugs are life-changing for some patients, they don't work for everyone. Now, UNC and UAB researchers present a simple test that aims to predict which treatment is most likely to work for each patient, an approach known as personalized or precision medicine.

Study Describes the Good and Bad Lung Bacteria in Cystic Fibrosis Patients

Mon, 20 Nov 2017 10:05:49 EST

(image) A large multicenter study found that patients with cystic fibrosis (CF) - who tend to develop chronic lung infections - had more good and bad bacteria in their lungs compared to controls. The study used bronchoalveolar lavage, in which a bronchoscope is directed into the lung to directly collect lung secretions, and also found less diversity of bacteria in the lungs of CF patients who were older and had more lung disease or inflammation. Results, published in the European Respiratory Journal, provide a basis for future treatment studies.

'Magic' Sinus Paths Could Mean New Instructions for Nasal Sprays

Mon, 20 Nov 2017 08:00:00 EST

(image) Sinus infections, inflammation and nasal congestion constantly plague Americans, often leading to unpleasant symptoms and even missed days of work. Traditional nasal spray anti-inflammatory medications attempt to treat the symptoms noninvasively, but are not very efficient in transmitting the active drug ingredients directly into the sinus cavities. Researchers from the University of North Carolina will present their research on the anatomy-based flow physics in nasal cavities which generate "magical" streamlines for sinus drug delivery at the 70th meeting of the Division of Fluid Dynamics, Nov. 19-21, 2017.